MOSCOW (Reuters) – Russia expects to produce between 1.5 million and 2 million doses per month of its potential COVID-19 vaccine by the year end, gradually ramping up production to 6 million doses a month, the RIA news agency cited industry minister Denis Manturov as saying on Sunday.
Large-scale testing of the vaccine, developed by Moscow’s Gamaleya institute, is due to start in Russia next week.
(Writing by Polina Ivanova; Editing by David Goodman)
